Non Small Cell Lung Cancer

 


Visitors: 604

Approximately 80 percent of people with lung cancer have non-small cell lung cancer. Depending on the type of cancer cell present, non-small cell cancer is in turn divided into several subtypes. Squamous cell carcinoma begins in thin, flat surface cells that line the respiratory tract, and is the most common type. Adenocarcinoma forms in cells that have a secretory or glandular function. Adenosquamous carcinoma begins in flattened cells that also have secretory properties. In sarcomatoid carcinoma, cells look markedly abnormal under the microscope. Carcinoid tumors grow slowly, and release hormones when stimulated by the nervous system. Cells in salivary glands in larger airways can also become cancerous.

Cancer cells in non-small cell lung cancer can produce hormones or hormone-like substances to cause certain conditions called paraneoplastic syndromes. These conditions include high blood calcium levels, abnormal clotting, overgrowth of certain bones and those in the fingertips in particular, and abnormal breast growth in men.

People with non-small cell lung cancer tend to be diagnosed later in the course of their disease, making these a difficult group of cancers to treat. The type of cancer, its location and stage, the presence of symptoms, and the patient’s overall condition and ability to withstand treatment all affect the ultimate outcome. Symptoms include breathlessness, chest pain, coughing up of blood, fatigue, fever and weight loss. A diagnosis is typically made by imaging, a lung biopsy, and blood tests.

Early non-small cell lung cancer can be treated by surgery. Once it spreads to surrounding chest tissues and to lymph nodes, chemotherapy and radiotherapy are frequently employed. Newer forms of treatment include laser therapy, photodynamic therapy, and biotherapy. The five-year survival rate for early non-small cell lung cancer is close to 50 percent; five-year survival drops to about two percent in the most advanced cases. A number of clinical trials are underway to find better treatment options. The National Cancer Institute website provides information on such trials.

Lung Cancer provides detailed information on Asbestos Lung Cancer, Lung Cancer, Lung Cancer Stages, Lung Cancer Survival Rate and more. Lung Cancer is affiliated with Asbestos Exposure .

(357)

Article Source:


 
Rate this Article: 
 
Overlooked Abnormal Cell Lung Cancer Has Its Pluses, or Shall I Say Managable ..
Rated 4 / 5
based on 5 votes
ArticleSlash

Related Articles:

What is Small Cell Lung Cancer (SCLC)?

by: Thomas Parker (December 29, 2008) 
(Cancer/Lung Mesothelioma Asbestos)

4 Useful Small Cell Lung Cancer Tests

by: Thomas Parker (December 31, 2008) 
(Cancer/Lung Mesothelioma Asbestos)

4 Top Non-Small Cell Lung Cancer Tests

by: Thomas Parker (January 04, 2009) 
(Cancer/Lung Mesothelioma Asbestos)

3 Possible Warning Signs For Non-Small Cell Lung Cancer

by: Thomas Parker (January 04, 2009) 
(Cancer/Lung Mesothelioma Asbestos)

3 Potential Small Cell Lung Cancer Symptoms

by: Thomas Parker (December 30, 2008) 
(Cancer/Lung Mesothelioma Asbestos)

3 Common Non-Small Cell Lung Cancer Risk Factors

by: Thomas Parker (January 03, 2009) 
(Cancer/Lung Mesothelioma Asbestos)

4 Major Risk Factors For Small Cell Lung Cancer

by: Thomas Parker (December 30, 2008) 
(Cancer/Lung Mesothelioma Asbestos)

3 Top Tips For Preventing Small Cell Lung Cancer

by: Thomas Parker (December 31, 2008) 
(Cancer/Lung Mesothelioma Asbestos)

DC-CIK cell immunotherapy can prevent advanced lung cancer metastasis

by: Kason Mou (June 25, 2011) 
(Health and Fitness/Diseases)

Overlooked Abnormal Cell Lung Cancer Has Its Pluses, or Shall I Say Managable ..

by: Jamie Quaranta (June 01, 2007) 
(Health and Fitness)